GO
Loading...

Pfizer Inc

More

  • Jan 20- Johnson& Johnson surprised investors by detailing the degree to which a strong dollar will hurt sales abroad this year, and industry watchers say Wall Street is underestimating the likely hit to other U.S.-based rivals such as Pfizer Inc and Merck& Co.. He predicted the stronger dollar will take a bigger bite out of other drugmakers' earnings than many...

  • Most active New York Stock Exchange-traded stocks Tuesday, 20 Jan 2015 | 1:33 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Alcoa Inc. rose 1.8 percent to $15.55 with 25,747,400 shares traded. Bank of America Corp. fell. 8 percent to $15.26 with 105,959,900 shares traded.

  • Midday Glance: Pharmaceuticals companies Tuesday, 20 Jan 2015 | 1:33 PM ET

    Baxter International Inc. fell$. 16 or. 2 percent, to $71.85. Bristol-Myers Squibb Co. fell$. 17 or. 3 percent, to $62.15. Hospira fell$. 02 or percent, to $63.20.

  • Early Glance: Pharmaceuticals companies Tuesday, 20 Jan 2015 | 10:33 AM ET

    Baxter International Inc. fell$. 36 or. 5 percent, to $71.65. Bristol-Myers Squibb Co. rose$. 08 or. 1 percent, to $62.39. Hospira fell$. 47 or. 7 percent, to $62.75.

  • LONDON, Jan 20- the international charity Medecins Sans Frontieres urged drugmakers GlaxoSmithKline and Pfizer on Tuesday to slash the price of their pneumococcal vaccines to $5 per child in poor countries. Pfizer also said its pneumococcal shot, Prevenar 13, was highly complex. It said GSK and Pfizer had together reported more than $19 billion in global...

  • Final Glance: Pharmaceuticals companies Friday, 16 Jan 2015 | 6:19 PM ET

    Baxter International Inc. rose$. 53 or. 7 percent, to $72.01. Bristol-Myers Squibb Co. rose$. 68 or 1.1 percent, to $62.31. Hospira rose $1.70 or 2.8 percent, to $63.22.

  • Midday Glance: Pharmaceuticals companies Friday, 16 Jan 2015 | 1:19 PM ET

    Baxter International Inc. rose$. 32 or. 4 percent, to $71.80. Bristol-Myers Squibb Co. rose$. 21 or. 3 percent, to $61.84. Hospira rose$. 90 or 1.5 percent, to $62.42.

  • Early Glance: Pharmaceuticals companies Friday, 16 Jan 2015 | 10:13 AM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $71.11. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $61.47. Hospira fell$. 20 or. 3 percent, to $61.32.

  • *Consumer more tenable as standalone business after Novartis deal. Chief Executive Andrew Witty told Reuters the group's large consumer health business would be more viable as a standalone operation following the conclusion of a $20 billion asset swap with Novartis, especially if it bought additional assets. "Post- Novartis, particularly if we did more...

  • Final Glance: Pharmaceuticals companies Thursday, 15 Jan 2015 | 6:08 PM ET

    Baxter International Inc. fell$. 25 or. 3 percent, to $71.48. Bristol-Myers Squibb Co. fell $1.32 or 2.1 percent, to $61.63. Hospira fell$. 28 or. 5 percent, to $61.52.

  • Midday Glance: Pharmaceuticals companies Thursday, 15 Jan 2015 | 1:59 PM ET

    Baxter International Inc. fell$. 41 or. 6 percent, to $71.32. Bristol-Myers Squibb Co. fell $1.41 or 2.2 percent, to $61.54. Hospira fell$. 20 or. 3 percent, to $61.60.

  • Early Glance: Pharmaceuticals companies Thursday, 15 Jan 2015 | 11:00 AM ET

    Baxter International Inc. fell$. 26 or. 4 percent, to $71.47. Bristol-Myers Squibb Co. fell$. 57 or. 9 percent, to $62.38. Hospira fell$. 48 or. 8 percent, to $61.32.

  • Final Glance: Pharmaceuticals companies Wednesday, 14 Jan 2015 | 6:07 PM ET

    Baxter International Inc. fell$. 24 or. 3 percent, to $71.73. Bristol-Myers Squibb Co. fell$. 17 or. 3 percent, to $62.95. Hospira rose$. 04 or. 1 percent, to $61.80.

  • NEW YORK, Jan 14- Surging U.S. stock-market volatility ahead of the earnings season is leading traders to lock in some gains in some big-cap companies that recently hit all-time highs, strategists said on Wednesday. Investors have grown worried about weak global growth and falling commodities prices, and drops in the S&P 500 stock index reflect that concern.

  • Midday Glance: Pharmaceuticals companies Wednesday, 14 Jan 2015 | 1:43 PM ET

    Baxter International Inc. fell$. 68 or. 9 percent, to $71.29. Bristol-Myers Squibb Co. fell$. 20 or. 3 percent, to $62.92. Hospira fell$. 45 or. 7 percent, to $61.31.

  • Most active New York Stock Exchange-traded stocks Wednesday, 14 Jan 2015 | 1:43 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Alcoa Inc. fell 5.4 percent to $14.95 with 54,387,900 shares traded. Bank of America Corp. fell 2.5 percent to $16.04 with 154,316,300 shares traded.

  • Early Glance: Pharmaceuticals companies Wednesday, 14 Jan 2015 | 10:41 AM ET

    Baxter International Inc. fell$. 56 or. 8 percent, to $71.41. Bristol-Myers Squibb Co. fell$. 20 or. 3 percent, to $62.92. Hospira rose$. 16 or. 3 percent, to $61.92.

  • *AstraZeneca sees $3.5 bln sales, analysts' numbers lower. *AstraZeneca shares up 1.5 percent. LONDON, Jan 14- AstraZeneca's blood-thinning drug Brilinta cut the risk of death or heart attack in patients with a history of previous attacks, according to a major clinical trial that will boost hopes for the closely watched product.

  • *AstraZeneca shares up 1.5 percent. LONDON, Jan 14- AstraZeneca's blood-thinning drug Brilinta cut the risk of death or heart attack in patients with a history of previous attacks, according to a major clinical trial that will boost hopes for the product. But AstraZeneca Chief Executive Pascal Soriot has made it a top priority and the company flagged Brilinta's...

  • Final Glance: Pharmaceuticals companies Tuesday, 13 Jan 2015 | 6:15 PM ET

    Baxter International Inc. fell$. 75 or 1.0 percent, to $71.97. Bristol-Myers Squibb Co. rose$. 94 or 1.5 percent, to $63.12. Hospira rose$. 21 or. 3 percent, to $61.76.